Live Breaking News & Updates on Exome asset management

Stay informed with the latest breaking news from Exome asset management on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Exome asset management and stay connected to the pulse of your community

Sutro Biopharma, Inc. (NASDAQ:STRO) Receives $12.57 Average Price Target from Brokerages

Sutro Biopharma, Inc. (NASDAQ:STRO) Receives $12.57 Average Price Target from Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Nicki-vasquez , Sutro-biopharma , Piper-sandler , Vanguard-group-inc , Exome-asset-management , Barclays-plc , Nuveen-asset-management , Nasdaq , Virtu-financial , Sutro-biopharma-inc , Securities-exchange-commission , Get-free-report

IGM Biosciences (NASDAQ:IGMS) Receives Neutral Rating from HC Wainwright

IGM Biosciences (NASDAQ:IGMS) Receives Neutral Rating from HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canada , Misbah-tahir , Royal-bank , Biosciences-inc , Barclays-plc , Goldman-sachs-group-inc , Exome-asset-management , Pricet-rowe-associates-inc , Free-report , Moderate-buy , Get-free-report , Advisors-lp-baker

Procaps Group (NASDAQ:PROC) Trading Down 3%

Procaps Group (NASDAQ:PROC) Trading Down 3%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Citadel-advisors , Institutional-investors-weigh-in-on-procaps-group , Geode-capital-management , Procaps-group , News-ratings-for-procaps-group-daily , Exome-asset-management , Procaps-group-stock-performance , Millennium-management , Procaps-group-company-profile , Get-free-report , Asset-management

Procaps Group (NASDAQ:PROC) Shares Down 3%

Procaps Group (NASDAQ:PROC) Shares Down 3%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Millennium-management , News-ratings-for-procaps-group-daily , Exome-asset-management , Procaps-group , Geode-capital-management , Hedge-funds-weigh-in-on-procaps-group , Citadel-advisors , Procaps-group-trading , Get-free-report , Asset-management , Capital-management

Regulus Therapeutics Inc. (NASDAQ:RGLS) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Regulus Therapeutics Inc. (NASDAQ:RGLS – Get Free Report) has earned an average recommendation of “Moderate Buy” from the five analysts that are currently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average 12 month […]

United-states , Canaccord-genuity-group , Regulus-therapeutics-inc , Nasdaq , Hermes-inc , Exome-asset-management , Wells-fargo-company , Vanguard-group-inc , Regulus-therapeutics-company-profile , Victory-capital-management-inc , Regulus-therapeutics

Geron (NASDAQ:GERN) Rating Reiterated by Wedbush

Geron (NASDAQ:GERN – Get Free Report)‘s stock had its “outperform” rating reissued by stock analysts at Wedbush in a report issued on Wednesday, Benzinga reports. They presently have a $6.00 price objective on the biopharmaceutical company’s stock. Wedbush’s price target would suggest a potential upside of 71.92% from the company’s current price. Several other analysts […]

United-states , American , Geron-corporation , Needham-company , American-international-group-inc , Goldman-sachs-group , Vanguard-group-inc , Capital-partners , Exome-asset-management , Pricet-rowe-associates-inc , Get-free-report

Geron's (GERN) "Outperform" Rating Reaffirmed at Wedbush

Geron (NASDAQ:GERN – Get Free Report)‘s stock had its “outperform” rating reiterated by Wedbush in a research note issued to investors on Wednesday, Benzinga reports. They currently have a $6.00 price objective on the biopharmaceutical company’s stock. Wedbush’s target price indicates a potential upside of 71.92% from the company’s previous close. Other equities analysts have […]

United-states , American , Pricet-rowe-associates-inc , Exome-asset-management , Capital-partners , American-international-group-inc , Vanguard-group-inc , Goldman-sachs-group , Needham-company , Geron-corporation , Get-free-report

Geron (NASDAQ:GERN) Rating Reiterated by Wedbush

Geron (NASDAQ:GERN) Rating Reiterated by Wedbush
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United-states , American , Vanguard-group-inc , American-international-group-inc , Goldman-sachs-group , Needham-company , Geron-corporation , Pricet-rowe-associates-inc , Exome-asset-management , Capital-partners , Get-free-report

JMP Securities Reiterates "Market Outperform" Rating for MacroGenics (NASDAQ:MGNX)

JMP Securities restated their market outperform rating on shares of MacroGenics (NASDAQ:MGNX – Free Report) in a research report report published on Thursday, Benzinga reports. A number of other research firms have also recently commented on MGNX. BTIG Research boosted their price target on shares of MacroGenics from $12.00 to $24.00 and gave the stock […]

United-states , Ezio-bonvini , Jeffrey-stuart-peters , Barclays , Group-plc , Exome-asset-management , Perceptive-advisors , Citigroup , Barclays-plc , Securities-exchange-commission , Macrogenics-inc , Free-report

StockNews.com Initiates Coverage on Regulus Therapeutics (NASDAQ:RGLS)

StockNews.com Initiates Coverage on Regulus Therapeutics (NASDAQ:RGLS)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , Leerink-partnrs , Wells-fargo-company , Nasdaq , Canaccord-genuity-group , Victory-capital-management-inc , Regulus-therapeutics-inc , Exome-asset-management , Regulus-therapeutics-company-profile , Prelude-capital-management , Renaissance-technologies , Regulus-therapeutics